首页> 美国卫生研究院文献>Clinical and Molecular Hepatology >A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

【2h】

A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

机译：索拉非尼和节律化学疗法治疗巴塞罗那肝功能差的C期肝细胞癌的比较研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background/AimsMetronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS) of MET compared to sorafenib for advanced hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT).

机译：背景/目的经常以相对较低的剂量作为连续化学治疗剂来施用都市化学疗法（MET）。这项研究的目的是评估与索拉非尼相比，MET对晚期肝细胞癌（HCC）门静脉肿瘤血栓形成（PVTT）患者的可行性和总生存期（OS）。

著录项

期刊名称 Clinical and Molecular Hepatology
作者
Hyun Yang; Hyun Young Woo; Soon Kyu Lee; Ji Won Han; Bohyun Jang; Hee Chul Nam; Hae Lim Lee; Sung Won Lee; Do Seon Song; Myeong Jun Song; Jung Suk Oh; Ho Jong Chun; Jeong Won Jang; Angelo Lozada; Si Hyun Bae; Jong Young Choi; Seung Kew Yoon;
展开▼
作者单位

展开▼
年(卷),期 2017(23),2
年度 2017
页码 128–137
总页数 10
原文格式 PDF
正文语种
中图分类分子生物学;
关键词
Carcinoma Hepatocellular; Administration Metronomic; Portal vein; Sorafenib; Thrombosis;

机译：肝细胞癌;行政管理门静脉;索拉非尼;血栓形成;

相似文献

外文文献
中文文献
专利

1. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients [J] . Feng Xia, Li-Li Wu, Hong-Bo Huan, World Journal of Gastroenterology . 2016,第23期

机译：巴塞罗那临床肝癌C期肝细胞癌患者肝切除术后辅助索拉非尼
2. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients [J] . Feng Xia, Li-Li Wu, Hong-Bo Huan, World Journal of Gastroenterology . 2016,第23期

机译：巴塞罗那临床肝癌C期肝细胞癌患者肝切除术后辅助索拉非尼
3. Transcatheter hepatic arterial infusion chemotherapy vs sorafenib in the treatment of patients with hepatocellular carcinoma of Barcelona Clinic Liver Cancer stage C: a meta-analysis of Asian population [J] . Jia-Yan Ni, Shan-Shan Liu, Hong-Liang Sun, OncoTargets and therapy . 2018,第2期

机译：经转截管肝动脉输液化疗与索拉非尼治疗巴塞罗那临床肝癌肝癌患者C：亚洲人口的荟萃分析
4. Magnetically Targeted Delivery of Sorafenib Through Magnetic Solid Lipid Nanoparticles Towards Treatment of Hepatocellular Carcinoma [C] . F. Vischio, N. Depalo, R. M. Iacobazzi, NATO Advanced Study Institute on Detection, Diagnosis and Health Concerns of Toxic Chemical and Biological Agents . 2020

机译：通过磁性固体脂质纳米粒子致磁性固体脂质纳米粒子对肝细胞癌治疗的磁性靶向递送
5. Poly(lactide-co-glycolide) Microspheres for Localized, Magnetic Resonance Imaging Monitored, Transcatheter Delivery of Sorafenib to Hepatocellular Carcinoma. [D] . Chen, Jeane. 2015

机译：聚（丙交酯-共-乙交酯）微球体用于局部监测，磁共振成像监测，索拉非尼经导管输送至肝细胞癌。
6. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients [O] . Feng Xia, Li-Li Wu, Wan-Yee Lau, 2016

机译：巴塞罗那临床肝癌C期肝细胞癌患者肝切除术后辅助索拉非尼
7. A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function [O] . Hyun Yang, Hyun Young Woo, Soon Kyu Lee, 2017

机译：索拉非尼与节律化疗对比较研究巴塞罗那临床肝癌 - 肝功能不全的C期肝细胞癌

A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅